BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1571422)

  • 1. Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review.
    Singh N; Yu VL
    Clin Infect Dis; 1992 Jan; 14(1):156-61. PubMed ID: 1571422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium chelonae infection following a total knee arthroplasty.
    Pring M; Eckhoff DG
    J Arthroplasty; 1996 Jan; 11(1):115-6. PubMed ID: 8676110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
    Zahid MA; Klotz SA; Goldstein E; Bartholomew W
    Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
    Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Mycobacterium chelonae keratitis with amikacin, doxycycline and topical ciprofloxacin.
    Probst LE; Brewer LV; Hussain Z; Tokarewicz AC
    Can J Ophthalmol; 1994 Apr; 29(2):81-4. PubMed ID: 8069760
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of lung infection due to Mycobacterium abscessus].
    Tagawa A; Ikehara K; Nishiyama H; Tsuburai T; Shinohara T; Kusano N; Baba T; Shoji A; Kaneko T; Suzuki S; Ishigatsubo Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):546-50. PubMed ID: 14503341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary resection for mycobacterium chelonae infection.
    Goto T; Hamaguchi R; Maeshima A; Oyamada Y; Kato R
    Ann Thorac Cardiovasc Surg; 2012; 18(2):128-31. PubMed ID: 22001214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin therapy of Mycobacterium chelonae keratitis.
    Hwang DG; Biswell R
    Am J Ophthalmol; 1993 Jan; 115(1):114-5. PubMed ID: 8420364
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral Mycobacterium chelonae keratitis following LASIK.
    Verma S; Watson SL; Dart JK; Eykyn SJ
    J Refract Surg; 2003; 19(3):379-80. PubMed ID: 12777038
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium chelonae empyema in an immunocompetent patient.
    Hsieh HC; Lu PL; Chen TC; Chang K; Chen YH
    J Med Microbiol; 2008 May; 57(Pt 5):664-667. PubMed ID: 18436603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal abscess caused by Mycobacterium chelonae and treatment.
    Idemyor V; Cherubin CE
    Ann Pharmacother; 1993 Feb; 27(2):178-9. PubMed ID: 8439693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterium chelonae myositis].
    Hajjaji N; Cattier B; Lanotte P; Legras A; Perrotin D
    Presse Med; 2004 Dec; 33(21):1519-20. PubMed ID: 15614176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients.
    Jacobson K; Garcia R; Libshitz H; Whimbey E; Rolston K; Abi-Said D; Raad I
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):615-21. PubMed ID: 9832262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
    Xia X; Gui X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P; Sultan F; Wallace RJ; Fraser V
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.